Captrust Financial Advisors Nektar Therapeutics Transaction History

Captrust Financial Advisors

$38.8 Billion
Q1 2025

A detailed history of Captrust Financial Advisors transactions in Nektar Therapeutics stock. As of the latest transaction made, Captrust Financial Advisors holds 32,152 shares of NKTR stock, worth $758,787. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,152

Previous 12,001 167.91%

Holding current value

$758,787

Previous $11,000 90.91%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$0.66 - $1.19 $13,299 - $23,979	20,151 Added 167.91%	32,152 $21,000
Q4 2024 Feb 14, 2025	SELL	$0.9 - $1.45 $672 - $1,083	-747 Reduced 5.86%	12,001 $11,000
Q3 2024 Nov 14, 2024	BUY	$1.11 - $1.48 $830 - $1,107	748 Added 6.23%	12,748 $16,000
Q1 2024 May 15, 2024	SELL	$0.49 - $0.96 $11 - $23	-24 Reduced 0.2%	12,000 $11,000
Q4 2023 Feb 14, 2024	SELL	$0.42 - $0.57 $2,578 - $3,499	-6,139 Reduced 33.8%	12,024 $6,000
Q3 2023 Nov 14, 2023	BUY	$0.51 - $1.05 $1,824 - $3,756	3,578 Added 24.53%	18,163 $10,000
Q2 2023 Aug 14, 2023	SELL	$0.53 - $1.03 $2,441 - $4,744	-4,606 Reduced 24.0%	14,585 $8,000
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $12,282 - $60,451	19,191 New	19,191 $13,000
Q3 2022 Nov 16, 2022	BUY	$3.04 - $5.14 $60,064 - $101,556	19,758 Added 600.36%	23,049 $74,000
Q2 2022 Aug 16, 2022	BUY	$3.17 - $6.17 $1,157 - $2,252	365 Added 12.47%	3,291 $13,000
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $4,147 - $13,678	997 Added 51.68%	2,926 $16,000
Q4 2021 Feb 14, 2022	BUY	$10.83 - $18.41 $2,815 - $4,786	260 Added 15.58%	1,929 $26,000
Q3 2021 Nov 16, 2021	BUY	$13.07 - $18.84 $731 - $1,055	56 Added 3.47%	1,669 $30,000
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $198 - $244	-12 Reduced 0.74%	1,613 $28,000
Q1 2021 May 17, 2021	BUY	$16.56 - $25.46 $21,114 - $32,461	1,275 Added 364.29%	1,625 $32,000
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $946 - $1,141	60 Added 20.69%	350 $6,000
Q3 2020 Nov 17, 2020	BUY	$16.59 - $24.79 $4,811 - $7,189	290 New	290 $5,000
Q3 2019 Nov 14, 2019	SELL	$16.91 - $36.27 $1,014 - $2,176	-60 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$31.0 - $36.3 $1,860 - $2,178	60 New	60 $2,000

Others Institutions Holding NKTR

# of Institutions

Shares Held

16.8M

Call Options Held

17.2K

Put Options Held

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $4.42B
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Nektar Therapeutics Transaction History